Plaintiffs filing Tepezza hearing loss lawsuits claim Horizon Therapeutics, the manufacturer, knew for years that the thyroid eye disease was linked to widespread reports of hearing problems.
Plaintiffs and defendants in Tepezza litigation have filed dueling bellwether selection protocols which would lead to the first early test cases over claims the thyroid eye disease drug causes hearing…
A Tepezza hearing loss lawsuit claims a man suffered permanent hearing damage after receiving infusions of the thyroid eye disease drug.
The initial status conference for Tepezza hearing damage lawsuits consolidated before one judge for pretrial proceedings, is scheduled for June 28.
A group of Tepezza lawyers has proposed a leadership plan for the recently consolidated claims of hearing loss linked to the thyroid eye disease drug.
Lawsuits continue to be filed against Horizon Pharmaceuticals over their failure to warn patients and doctors about the long term hearing loss side effects from Tepezza.
The U.S. Judicial Panel on Multidistrict Litigation has agreed to hear oral arguments over whether all Tepezza hearing loss lawsuits filed in federal courts nationwide should be centralized and consolidated…
A Tepezza hearing injury lawsuit accuses the manufacturer of failing to provide adequate adverse side effect warnings to patients and the medical community.
A Pennsylvania woman says she suffered permanent hearing loss as the result of a series of Tepezza infusions designed to treat her thyroid eye disease.
A new case study found that cutting the dosage in half helped resolve many Tepezza hearing loss problems and other adverse side effects linked to the thyroid eye disease drug.
